Rivaroxaban in Idiopathic Membranous Nephropathy

Clinical trial NCT07404436 · RECRUITING

Trial details

NCT number: NCT07404436
Sponsor: Beijing Friendship Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Idiopathic Membranous Nephropathy

Start date: 2024-01-05
Primary completion: 2026-12-31
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.